Chongqing Daxin Pharmaceutical Co., Ltd
Business Type:Trading Company
- Main Products:
- Year Established:
- 2014
Chongqing Daxin Pharmaceutical Co., Ltd. (herein referred as Chongqing Daxin) was established in 1941. It is a core member of PKU HealthCare Industry，which has been praised as the Key High-tech Enterprise of the National Torch Program, Nationwide Key Enterprise in Chemical and Pharmaceutical Industry, one of the National Top 100 Pharmaceutical Enterprises and the Exportation brand leader enterprise supported by Chongqing government. After over 70 year's development, it has become a biotech orien...
MoreCompany Authentication
Time of verification: | 2015-4-24 15:20 | |
Company Name: | Chongqing Daxin Pharmaceutical Co., Ltd | |
Country/Territory: | China (Mainland) | |
Registered Address: | No.21, Fangzheng Avenue, Beibei District, Chongqing 400700,P.R.China | |
Company Scale: |
Above 1000 | |
Registered Capital: |
100000000 |
|
Business Type: |
True |
|
Business Scope: |
APIs------Lovastatin, Simvastatin, Mevastatin(Compactin), Mycophenolic, Mycophenolate Mofetil,Sirolimus（Rapamycin), Tobramycin,Tobramycin Sulfate, Daptomycin,Vancomycin HCI, Vancomycin, Amikacin, Amikacin Sulfate, Midecamycin, Meleumycin, Moxdectin, Milbemycin Oxime, Doramectin, and so on. |
|
Main Markets: |
North America South America Eastern Europe Southeast Asia Africa Mid East Eastern Asia Western Europe |
|
Company Corporate Representative: | Bona Peng |
Certificate
Business License: |
|
Tax Registration Certificate: |
|
Organization Code Certificate: |
|
Legal person's id card: |